The Thoracic-POISE trial is largest-ever research trial on the combination of naturopathic and conventional treatment. This 11-year trial will study the impact of integrating naturopathic medicine, surgery, and oncology for people with lung, gastric and esophageal cancers. The lead investigator for this trial is Dugald Seely, ND. Join us to learn about this trial and what it has discovered already!
About Dugald Seely, ND
Dr. Dugald Seely leads the clinical practice and cancer research agenda for the Ottawa Integrative Cancer Centre. In addition to his clinical role as a naturopathic doctor he also serves as the director of research & clinical epidemiology at the Canadian College of Naturopathic Medicine, affiliate investigator for the Ottawa Hospital Research Institute, and peer reviewer for Health Canada’s Canadian Adverse Reaction Newsletter.
Dugald completed his M.Sc. in cancer research at the University of Toronto. He is also Fellow of the American Board of Naturopathic Oncology (FABNO). Awarded competitive grant and trainee funding from CIHR, the SickKids Foundation, and the Lotte and John Hecht Memorial Foundation, Dugald is the principal investigator for a number of clinical trials and synthesis projects.